Results 101 to 110 of about 659,528 (297)

PNEUMOCOCCAL INFECTION — IN THE CENTRE OF ATTENTION AGAIN

open access: yesВопросы современной педиатрии, 2009
This article present a general review on pneumococcal infection, its prevalence, clinic types in children in Russia and worldwide. Description of S. pneumoniae serotypes' distribution and its influence at clinical manifestation of pneumococcal infection ...
S.V. Sidorenko
doaj   +2 more sources

Pneumococcal vaccines in China

open access: yesHuman Vaccines & Immunotherapeutics
Invasive pneumococcal disease (IPD) is a serious global public health problem and the leading cause of morbidity and mortality in children and adults in China. Thus, developing and administering pneumococcal vaccines are important for disease prevention.
Shanshan Wang   +6 more
openaire   +3 more sources

Effectiveness of the 23-Valent Pneumococcal Polysaccharide Vaccine (PPV23) against Pneumococcal Disease in the Elderly: Systematic Review and Meta-Analysis

open access: yesPLoS ONE, 2017
Background Routine vaccination of elderly people against pneumococcal diseases is recommended in many countries. National guidelines differ, recommending either the 23-valent polysaccharide vaccine (PPV23), the 13-valent conjugate vaccine (PCV13) or both.
G. Falkenhorst   +5 more
semanticscholar   +1 more source

Disparities in Respiratory Syncytial Virus Vaccine Uptake in the Medicare Fee‐for‐Service Population During 2023–2024 Season

open access: yesJournal of the American Geriatrics Society, EarlyView.
ABSTRACT Background Respiratory syncytial virus (RSV) is a common cause of acute respiratory illness and can lead to serious morbidity and mortality in older adults. With the Food and Drug Administration approval and the Centers for Disease Control and Prevention (CDC) recommendation of RSV vaccines in 2023, this study describes first season vaccine ...
Austin Murphy   +7 more
wiley   +1 more source

Clinical and bacteriological characteristics of invasive pneumococcal disease after pneumococcal 10-valent conjugate vaccine implementation in Salvador, Brazil

open access: yesBrazilian Journal of Infectious Diseases, 2016
Invasive pneumococcal disease is a relevant public health problem in Brazil, especially among children and the elderly. In July/2010 a 10-valent pneumococcal conjugate vaccine was introduced to the immunization schedule of Brazilian children under two ...
Carolina Regis Leite   +5 more
doaj  

Reactogenicity, safety and immunogenicity of a protein-based pneumococcal vaccine in Gambian children aged 2–4 years: A phase II randomized study

open access: yesHuman Vaccines & Immunotherapeutics, 2015
Pneumococcal conjugate vaccines (PCVs) have been successful in preventing invasive pneumococcal disease but effectiveness has been challenged by replacement of vaccine serotypes with non-vaccine serotypes. Vaccines targeting common pneumococcal protein(s)
A. Odutola   +11 more
semanticscholar   +1 more source

CAR‐T Cell Therapy in Autoimmune Setting: A New Appealing Approach Extendable to Allergy?

open access: yes
Allergy, EarlyView.
Federico Rossi   +2 more
wiley   +1 more source

What Are the Infection Prevention Behaviors of Kidney Transplant Recipients and the Factors Related to These?

open access: yesJournal of Clinical Nursing, EarlyView.
ABSTRACT Background The infection prevention behaviours of kidney transplant recipients have been investigated, but the factors affecting these have not. Therefore, the present study aimed to examine the infection prevention behaviours of kidney transplant recipients and the factors related to these.
Yaprak Sarıgöl Ordin   +1 more
wiley   +1 more source

Improving Pneumococcal Vaccination Rates in Jefferson Hospital Ambulatory Practice Patients [PDF]

open access: yes, 2017
AIM: To improve the pneumococcal vaccination initiation rates in patients 65 years and older in Jefferson Hospital Ambulatory Practice (JHAP) to the institutional quality measure goal of 80% over a 4 month period from January to May of 2017.https://jdc ...
Enriquez, MD, Matthew   +3 more
core   +1 more source

Acquisition of pneumococci specific effector and regulatory Cd4+ T cells localising within human upper respiratory-tract mucosal lymphoid tissue [PDF]

open access: yes, 2011
The upper respiratory tract mucosa is the location for commensal Streptococcus (S.) pneumoniae colonization and therefore represents a major site of contact between host and bacteria.
AD Reynolds   +62 more
core   +3 more sources

Home - About - Disclaimer - Privacy